Australia markets closed

Trinity Biotech plc (TRIB)

NasdaqGS - NasdaqGS Delayed price. Currency in USD
Add to watchlist
1.8022+0.1122 (+6.64%)
At close: 04:00PM EDT
1.8400 +0.04 (+2.10%)
After hours: 07:26PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 17.06M
Enterprise value 80.79M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.06
Price/book (mrq)5.11
Enterprise value/revenue 1.42
Enterprise value/EBITDA -3.35

Trading information

Stock price history

Beta (5Y monthly) 1.23
52-week change 3-66.06%
S&P500 52-week change 322.38%
52-week high 35.5000
52-week low 31.6600
50-day moving average 32.0328
200-day moving average 32.7345

Share statistics

Avg vol (3-month) 318.09k
Avg vol (10-day) 310.17k
Shares outstanding 59.47M
Implied shares outstanding 67.64M
Float 869.35M
% held by insiders 123.67%
% held by institutions 131.57%
Shares short (15 Apr 2024) 41.86k
Short ratio (15 Apr 2024) 40.1
Short % of float (15 Apr 2024) 40.04%
Short % of shares outstanding (15 Apr 2024) 40.02%
Shares short (prior month 15 Mar 2024) 44.3k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 41.19
Payout ratio 40.00%
Dividend date 301 July 2015
Ex-dividend date 405 June 2015
Last split factor 21:5
Last split date 323 Feb 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -42.26%
Operating margin (ttm)-25.98%

Management effectiveness

Return on assets (ttm)-13.15%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)56.83M
Revenue per share (ttm)7.42
Quarterly revenue growth (yoy)-25.60%
Gross profit (ttm)N/A
EBITDA -14.16M
Net income avi to common (ttm)-36.87M
Diluted EPS (ttm)-4.8000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)3.69M
Total cash per share (mrq)0.02
Total debt (mrq)54.86M
Total debt/equity (mrq)N/A
Current ratio (mrq)2.60
Book value per share (mrq)-3.12

Cash flow statement

Operating cash flow (ttm)-11.56M
Levered free cash flow (ttm)-11.02M